Exercising restraint to stall tumor growth

August 27, 2014, Agency for Science, Technology and Research (A*STAR), Singapore
The location of GalNAc-T enzymes (red) and the endoplasmic reticulum (ER; green) in normal cells (top). When the signaling protein ERK8 is inhibited, GalNAc-Ts move from the Golgi to the ER (yellow staining; bottom). Credit: Reproduced from Ref. 1 and licensed under CC BY 3.0  © 2014 J. Chia et al.

Many proteins undergo an assembly line-style process of glycosylation as they travel from a cellular structure called the endoplasmic reticulum (ER) to the Golgi apparatus and on through its various compartments, after which they are released. Disruptions in this process can contribute to a variety of diseases. Now researchers from A*STAR have identified a regulatory mechanism that prevents the production of glycosylated proteins that potentially promote cancerous growth1.

The process—executed by various enzymes in a stepwise fashion—attaches complex sugar molecules onto proteins, which can fundamentally alter the destination and function of these proteins in the cell. Many tumors produce proteins that are known as 'Tn antigens': these proteins have been decorated with a single sugar molecule by enzymes from the N-Acetylgalactosaminyltransferase (GalNAc-T) family.

GalNAc-T enzymes normally reside within the Golgi, but Frederic Bard and colleagues at the A*STAR Institute of Molecular and Cell Biology in Singapore previously showed that these enzymes relocate to the ER in certain tumors2. Here they target resident proteins for modification and thus contribute to Tn production.

To better understand why this happens, Bard's team screened more than 900 that affect Tn levels. Remarkably, their experiments uncovered a dozen different proteins that appear to ensure that GalNAc-T enzymes are retained within the Golgi instead of being delivered to the ER. "We were surprised by the number of regulators that we could identify," says Bard. One of these, a signaling protein called extracellular signal regulated kinase 8 (ERK8), appeared to be particularly important for restricting Tn accumulation to the Golgi.

When the researchers inhibited production of ERK8, they observed a clear redistribution of GalNAc-Ts from the Golgi to the ER, indicating that this protein normally puts the brakes on such 'backward' traffic (see image). "After knocking down ERK8, the relocation pathway responds like a compressed spring that has just been released," says Bard. The subsequent production of Tn antigens stimulates the active cell migration observed in aggressive cancers, and ERK8 similarly appears to act as a critical check against this behavior in cultured cancer cells.

The researchers also noted unusually low ERK8 levels in tumor tissue taken from breast and . Bard's team is now working with animal models to determine the importance of this as a safeguard against cancerous growth. "We are building a mouse model where we can experimentally remove ERK8 and observe the effects in healthy and cancer tissues," says Bard. "We predict that loss of ERK8 will promote tumor invasiveness."

Explore further: Disruptions in a protein-processing pathway appear to promote aggressive proliferation and invasion in tumor cells

More information: 1. Chia, J., Tham, K. M., Gill, D. J., Bard-Chapeau, E. A. & Bard, F. A. ERK8 is a negative regulator of O-GalNAc glycosylation and cell migration. eLife 3, e01828 (2014). dx.doi.org/10.7554/eLife.01828

2. Gill, D. J., Tham, K. M., Chia, J., Wang, S. C., Steentoft, C. et al. Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proceedings of the National Academy of Sciences USA 110, E3152–E3161 (2013). dx.doi.org/10.1073/pnas.1305269110

Related Stories

Disruptions in a protein-processing pathway appear to promote aggressive proliferation and invasion in tumor cells

January 29, 2014
Many proteins at the cell surface are 'decorated' with carbohydrate molecules called glycans. Changes in a cell's glycan profile can greatly alter how it behaves and interacts with its environment, and abnormalities in this ...

New technology offers insight into cholesterol

August 14, 2014
With new advanced techniques developed by the Copenhagen Center for Glycomics at the University of Copenhagen it is possible to study cells in greater detail than ever before. The findings have just been published in the ...

High-resolution 3-D imaging draws new picture of Golgi's whereabouts during cell division

December 15, 2013
Resolving a fundamental question in cell biology and showing off the powers of new high-resolution 3-D imaging, NIH scientists have discovered where the Golgi apparatus, which sorts newly synthesized proteins for transport ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.